Doubts and expectation about Moderna Therapeutics, the superstar among all biotechs

The Financial Times has published a fairly critical article against Cambridge, Massachussets-based biotech Moderna Therapeutics, developer of a technology based on “messenger RNAs”, likely to mean a breakthrough in the treatment approach to many rare conditions for which no cure exists.